Synchrony Medical develops an airway clearance system for people with chronic lung diseases.
Synchrony Medical develops the LibAirty Airway Clearance System, which combines guided breathing and chest compressions to help clear mucus from the lungs. The device is intended for patients with chronic respiratory conditions and for healthcare providers. Founded in 2020, the company is based in Jersey City, US. In August 2025, it raised USD 4.3 million in seed funding led by Edge Medical Ventures, with participation from New Jersey Economic Development Authority, Broadfin Capital and Consensus Business Group.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in